Erlotinib for Treatment of Psoriasis

NCT01006096 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IND not obtained

Conditions

Psoriasis

Interventions

DRUG: erlotinib
OTHER: placebo tablet

Sponsor

Northwestern University

Collaborators

[object Object]